The copycat drug was launched at about a 5% discount, adding to the growing competition for the blockbuster rheumatoid arthritis drug in the U.S.
Posts
The copycat drug called Hadlima will be listed at $1,038 per month, representing an 85% discount of Humira’s current $6,922 monthly price, the companies said.
